Balance Sheet Components

3 Months Ended

Mar. 31, 2026

Note 6. Balance Sheet Components

Accrued Liabilities

Accrued liabilities consist of the following (in thousands):


	March 31,		December 31,
	2026		2025
Accrued research and development-related expenses	$	1,311	$	1,650
Accrued clinical trial-related expenses		222		268
Accrued professional services expenses		103		84
Accrued offering costs		75		—
Other		56		50
Total accrued liabilities	$	1,767	$	2,052